| Controversies in HIV Cure Research |
MOSA02 |
|
|
|
|
| Organiser: |
amfAR, The Foundation for AIDS Research and the International AIDS Society (IAS) |
| Type: |
|
Non-Commercial Satellite |
Back
|
|
| Venue: |
SR 3 |
| Time: |
18:30 - 20:30, 18.07.2011 |
| Code: |
MOSA02 |
|
Chairs:
|
Rowena Johnston, United States
Steven Deeks, United States
Rafick-Pierre Sékaly, Canada
Mark Harrington, United States
Françoise Barré-Sinoussi, France
|
|
|
|
While it is known that antiretroviral therapy does not cure HIV infection, several controversies in the field of HIV cure research remain unresolved and have the potential to redirect lines of scientific inquiry including strategies aimed at curing HIV infection. In this session, basic and clinical research experts will present evidence for each side of the debates around three controversies drawn from basic, preclinical and clinical research. A moderator for each debate will pose questions to each speaker and field questions from the audience.
|
|
Presentations in this session:
18:30
| Introductions
| 18:45
Powerpoint | Is there ongoing replication under HAART?
Presented by Mario Stevenson, United Kingdom
Frank Maldarelli, United States
| 18:55
| Discussion
| 19:25
Powerpoint | Will cell and animal models be informative in planning clinical trials for a cure (or will we only learn from doing the trials)?
Presented by Guido Silvestri, United States
Alan Landay, United States
| 19:30
| Discussion
| 20:00
Powerpoint | Are we most likely to cure HIV with gene therapy?
Presented by Keith R. Jerome, United States
Sharon Lewin, Australia
| 20:05
| Discussion
| 20:25
Powerpoint | Closing
Presented by Françoise Barré-Sinoussi, France
|
|
| Powerpoints presentations |
| Is there ongoing replication under HAART? - Mario Stevenson | |
| Will cell and animal models be informative in planning clinical trials for a cure (or will we only learn from doing the trials)? - Guido Silvestri | | | Will cell and animal models be informative in planning clinical trials for a cure (or will we only learn from doing the trials)? - Alan Landay | |
| Are we most likely to cure HIV with gene therapy? - Sharon Lewin | | | Are we most likely to cure HIV with gene therapy? - Keith R. Jerome | |
| Closing - Françoise Barré-Sinoussi | |
|
|